HKMA published a circular on enhanced disclosure requirements on sale of structured products not regulated by the Securities and Futures Ordinance (SFO). Authorized institutions should implement the enhanced disclosure requirements set out in this circular before the end of 2018.
Senior management of authorized institutions has the responsibility to review and put in place adequate controls and practices, in addition to providing sufficient training and guidance to staff to ensure compliance with regulatory standards. As set out in the circular of December 20, 2012 entitled “Applicability of the SFC’s regulatory requirements to sale of structured products that are not regulated by the SFO,” HKMA expects authorized institutions to continue to apply consistently high standards and act in best interests of their customers in the sale of investment products. In selling investment products that are not regulated by the SFO, authorized institutions are reminded to follow similar standards as those applicable to SFO-regulated investment products.
In particular, HKMA expects authorized institutions to apply revised paragraphs 8.3 and 8.3A of the Code to their sale of structured products not regulated by the SFO, including but not limited to products that are linked to currency(ies) and/or interest rate(s). Following the revised paragraph 8.3(b)(ii) of the Code, where monetary benefits received or receivable by an authorized institution and/or any of its associates from a product issuer (directly or indirectly) for distributing a non-SFO-regulated structured product are not quantifiable prior to or at the point of entering into a transaction, the authorized institution should disclose the existence and nature of such monetary benefits, and the maximum percentage of such monetary benefits receivable per year prior to or at the point of entering into the transaction. The disclosure should be made on a transaction basis.
Keywords: Asia Pacific, Hong Kong, Securities, Disclosures, Structured Products, SFO, HKMA
BCBS amended the guidelines on sound management of risks related to money laundering and financing of terrorism (ML/FT).
EBA finalized the guidelines on treatment of structural foreign-exchange (FX) positions under Article 352(2) of the Capital Requirements Regulation (CRR).
FSB published a statement on the impact of COVID-19 pandemic on global benchmark transition.
IAIS published the list of Internationally Active Insurance Groups (IAIGs) publicly disclosed by group-wide supervisors.
FED has temporarily revised the reporting form on consolidated financial statements for holding companies (FR Y-9C; OMB No. 7100-0128).
EC launched a consultation on the review of the key elements of Solvency II Directive, with the comment period ending on October 21, 2020.
ECB launched a consultation on the guide that sets out supervisory approach to consolidation projects in the banking sector.
PRA published a letter that builds on the expectations set out in the supervisory statement (SS3/19) on enhancing banks' and insurers' approaches to managing the financial risks from climate change.
US Agencies (Farm Credit Administration, FDIC, FED, FHFA, and OCC) finalized changes to the swap margin rule to facilitate implementation of prudent risk management strategies at banks and other entities with significant swap activities.
IAIS published technical specifications, questionnaires, and templates for 2020 Insurance Capital Standard (ICS) and Aggregation Method data collections.